Merit Medical Systems, Inc. (MMSI)
Nasdaq · Healthcare · Medical Instruments & Supplies
$87.14+2.07%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $5.2B
- P/E (trailing)
- 35.9
- Forward P/E
- 18.9
- 52-week range
- $59.74 – $94.75
- 52-week change
- +3.23%
- EPS (trailing)
- $2.43
- Analyst rating
- 1.8 Buy
- Next earnings
- Oct 29, 2026
Fiscal year to Dec 2025
- Revenue
- $1.5B (+11.75%)
- Net income
- $128M
- Operating margin
- 12.2%
- Diluted EPS
- $2.13
- Free cash flow
- $216M
From the company’s annual report on SEC EDGAR.
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
Headquarters: South Jordan, United States · 7,500 employees · merit.com